Clinical Takeaway
People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to prevent evidence-based PTSD therapies from working, which supports offering these treatments rather than withholding them based on cannabis use status.
#5 Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data.
Citation: Hill Melanie L et al.. Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data.. Journal of anxiety disorders. 2024. PMID: 38266511.
Design: 6 Journal: 0 N: 4 Recency: 1 Pop: 2 Human: 1 Risk: -2
This meta-analysis addresses a critical clinical gap by examining whether evidence-based trauma-focused treatments maintain efficacy in the substantial subset of PTSD+SUD patients who use cannabis, a population often excluded from efficacy trials. The findings directly inform treatment selection and prognostication for complex patients in real-world settings where cannabis use is prevalent among trauma survivors seeking care. Understanding treatment response in cannabis-using populations is essential for establishing appropriate clinical expectations and identifying whether modified treatment protocols are necessary for this high-risk comorbid group.
Quality Gate Alerts:
- Preclinical only
Abstract: High rates of cannabis use among people with posttraumatic stress disorder (PTSD) have raised questions about the efficacy of evidence-based PTSD treatments for individuals reporting cannabis use, particularly those with co-occurring alcohol or other substance use disorders (SUDs). Using a subset of four randomized clinical trials (RCTs) included in Project Harmony, an individual patient meta-analysis of 36 RCTs (total N = 4046) of treatments for co-occurring PTSD+SUD, we examined differences in trauma-focused (TF) and non-trauma-focused (non-TF) treatment outcomes for individuals who did and did not endorse baseline cannabis use (N = 410; 70% male; 33.2% endorsed cannabis use). Propensity score-weighted mixed effects modeling evaluated main and interactive effects of treatment assignment (TF versus non-TF) and baseline cannabis use (yes/no) on attendance rates and within-treatment changes in PTSD, alcohol, and non-cannabis drug use severity. Results revealed significant improvements across outcomes among participants in all conditions, with larger PTSD symptom reductions but lower attendance among individuals receiving TF versus non-TF treatment in both cannabis groups. Participants achieved similar reductions in alcohol and drug use across all conditions. TF outperformed non-TF treatments regardless of recent cannabis use, underscoring the importance of reducing barriers to accessing TF treatments for individuals reporting cannabis use.
🧠 While this meta-analysis addresses a clinically relevant question about how cannabis use may affect trauma-focused treatment outcomes in patients with comorbid PTSD and substance use disorders, several important limitations warrant careful interpretation. The analysis draws from only four RCTs within a larger Project Harmony dataset, which constrains generalizability and statistical power for detecting meaningful subgroup effects, and the heterogeneity of cannabis use patterns (frequency, potency, timing relative to treatment) across studies likely obscures more nuanced dose-response relationships. Additionally, the meta-analysis cannot account for unmeasured confounders such as self-medication severity, baseline anxiety levels, or treatment adherence differences that might explain apparent outcome disparities rather than cannabis causation itself. From a clinical standpoint, these findings suggest that active cannabis use should not automatically be viewed as a contraindication to evidence-based trauma treatment, but rather as a factor requiring individualized assessment and possible concurrent substance use intervention, with particular attention to whether cannabis is being used to manage PTSD
| |